The Flibanserin drug works in a completely different way to Intrinsa...

When Viagra came onto the market and drug companies realised how much cash there was in treating male erectile dysfunction, within the space of a few years two competitors had launched their rival products meaning that now men have a big choice when it comes to erectile dysfunction medication. It looks like the female sexual dysfunction market could be going the same way. Intrinsa that is being dubbed ‘the female Viagra’ and which is now for sale in the United Kingdom is the first medication ever to be fully licensed for the treatment of female sexual problems. It is actually administered by the way of a patch that is worn on the skin and releases very small amounts of testosterone in to the bloodstream.

Hot on the heels of Intrinsa are many other research projects to help women with female sexual dysfunction but one of the most promising ones which we have been following for some time at Ukmedix News is Flibanserin which like many drugs was not originally tested for female sexual dysfunction but for something completely unrelated.

According to experts the Flibanserin drug works in a completely different way to Intrinsa in that it actively targets the zones of a woman’s brain that control pleasure and does not interfere with hormone levels. Originally the drug had been tested as an antidepressant and the testing was about to be discontinued when a bright researcher noted that many of the women using it reported that while it was not effective as an antidepressant they had noticed that their libido had increased significantly.

In the United States studies are going to start soon involving hundreds of women between the years of 18 and 45. If the drug works well the testing may be enlarged to include men as well, but for now the researchers are limiting their clinical trials to females. Ukmedix News reckon that Flibanserin is one to watch for the future.